UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab

Drug safety, 2018-12, Vol.41 (12), p.1397-1410

2018

Volltextzugriff (PDF)

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase

Drug safety, 2016-04, Vol.39 (4), p.335-345

2016

Volltextzugriff (PDF)

Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases

Drug safety, 2016-04, Vol.39 (4), p.355-364

2016

Volltextzugriff (PDF)

Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank

Drug safety, 2014-08, Vol.37 (8), p.617

2014

Volltextzugriff (PDF)

A Comparison of Active Adverse Event Surveillance Systems Worldwide

Drug safety, 2014-08, Vol.37 (8), p.581-596

2014

Volltextzugriff (PDF)

Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports

Drug safety, 2020-12, Vol.43 (12), p.1309-1314

2020

Volltextzugriff (PDF)

Traceability of Biopharmaceuticals in Spontaneous Reporting Systems: A Cross-Sectional Study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance Databases

Drug safety, 2013-08, Vol.36 (8), p.617-625

2013

Volltextzugriff (PDF)

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study

Drug safety, 2020-12, Vol.43 (12), p.1315-1322

2020

Volltextzugriff (PDF)

Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database

Drug safety, 2016-04, Vol.39 (4), p.347-354

2016

Volltextzugriff (PDF)

Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports

Drug safety, 2016-02, Vol.39 (2), p.185-192

2016

Volltextzugriff (PDF)

Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis

Drug safety, 2017-10, Vol.40 (10), p.923-932

2017

Volltextzugriff (PDF)

Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase

Drug safety, 2016-07, Vol.39 (7), p.689-696

2016

Volltextzugriff (PDF)

Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database

Drug safety, 2017-10, Vol.40 (10), p.895-909

2017

Volltextzugriff (PDF)

Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest

Drug safety, 2014-08, Vol.37 (8), p.557-567

2014

Volltextzugriff (PDF)

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

Drug safety, 2013-06, Vol.36 (6), p.467-479

2013

Volltextzugriff (PDF)

Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study

Drug safety, 2017-10, Vol.40 (10), p.887-893

2017

Volltextzugriff (PDF)

Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case–Control Analysis Using the Clinical Practice Research Datalink

Drug safety, 2016-04, Vol.39 (4), p.307-321

2016

Volltextzugriff (PDF)

Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale

Drug safety, 2016-10, Vol.39 (10), p.959-976

2016

Volltextzugriff (PDF)

Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies

Drug safety, 2014-10, Vol.37 (10), p.771-776

Gagne, Joshua J.

2014

Volltextzugriff (PDF)

Use of an On-demand Drug–Drug Interaction Checker by Prescribers and Consultants: A Retrospective Analysis in a Swiss Teaching Hospital

Drug safety, 2013-06, Vol.36 (6), p.427-434

2013

Volltextzugriff (PDF)

Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports

Drug safety, 2014-08, Vol.37 (8), p.609-616

2014

Volltextzugriff (PDF)

Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks

Drug safety, 2023-01, Vol.46 (1), p.39-52

2023

Volltextzugriff (PDF)

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Drug safety, 2018-07, Vol.41 (7), p.665-675

2018

Volltextzugriff (PDF)

Good Signal Detection Practices: Evidence from IMI PROTECT

Drug safety, 2016-06, Vol.39 (6), p.469-490

2016

Volltextzugriff (PDF)

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

Drug safety, 2016-08, Vol.39 (8), p.755-762

2016

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDrug Safety

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(127)

Sprache

Englisch
(127)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(122)
Pharmacology & Pharmacy
(122)
Public, Environmental & Occupational Health
(122)
Science & Technology
(122)
Toxicology
(122)
Medicine
(121)
Drug Safety And Pharmacovigilance
(120)
Medicine & Public Health
(120)
Pharmacology/toxicology
(120)
Humans
(112)
Original Research Article
(86)
Pharmaceutical Industry
(67)
Pharmacovigilance
(54)
Studies
(50)
Databases, Factual
(45)
Biological And Medical Sciences
(42)
Medical Sciences
(42)
Pharmacology. Drug Treatments
(42)
Drugs
(40)
Female
(38)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase

Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases

Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank

A Comparison of Active Adverse Event Surveillance Systems Worldwide

Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports

Traceability of Biopharmaceuticals in Spontaneous Reporting Systems: A Cross-Sectional Study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance Databases

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study

Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database

Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports

Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis

Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase

Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database

Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database

Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study

Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case–Control Analysis Using the Clinical Practice Research Datalink

Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale

Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies

Use of an On-demand Drug–Drug Interaction Checker by Prescribers and Consultants: A Retrospective Analysis in a Swiss Teaching Hospital

Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports

Individual Case Safety Report Replication: An Analysis of Case Reporting Transmission Networks

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

Good Signal Detection Practices: Evidence from IMI PROTECT

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis

Aktive Filter

Suchergebnisse filtern